Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin.
A 31-year-old woman, having a type-1 diabetes and an insulin allergy, was successfully treated with a subcutaneous antihistamine injection to the next continuous subcutaneous insulin infusion site.
Imakado
Sumihisa
S
Hamada
Kazutoshi
K
Atsumi
Yoshihito
Y
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000276:immunology; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000009:adverse effects*; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D011994:Recombinant Proteins / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects / Q000276:immunology / Q000473:pathology
D006633:Histamine Antagonists; D007328:Insulin; D011994:Recombinant Proteins